Bloqcube and NTT DATA Partner to Deliver Blockchain-Driven Management Solutions
BloqCube, a developer of a proprietary integrated clinical trial and financial management system employing innovative blockchain technology, and NTT DATA announced an alliance to benefit the healthcare and life sciences industry.
BloqCube will bring to the partnership its pioneering technology that speeds up clinical trials, by enhancing efficiencies of multiple related processes while retaining strong data security. NTT DATA will provide its expertise in enterprise-scale domain consulting, application implementation and integration services through the company’s healthcare and life sciences business consulting and blockchain technology competencies.
BloqCube uses proprietary algorithms to automate what is typically a laborious process of monitoring clinical trial sites (hospitals, treatment centers) and verifying data. Its C2TA technology delivers real-time accounting transaction records of payments and financial planning to clinical trial management. BloqCube is the first company to offer a fully integrated clinical management system leveraging blockchain technology to ensure data security and integrity while accelerating clinical trials and cutting costs.
BloqCube will benefit from NTT DATA’s experience in accelerating value-based healthcare, maximizing efficiency and delivering flexible solutions to achieve accuracy and customer satisfaction.
BloqCube CEO Rama K. Rao stated, “We are delighted to work with NTT DATA as both our organizations are clearly focused on improving patient outcomes. NTT DATA has a broad client base in the healthcare and life sciences industry that will be able to take advantage of our first-in-class clinical trial and financial management technology while BloqCube clients will benefit from NTT DATA’s enterprise-scale services.”
BloqCube participated in the New Jersey Innovation Institute (NJII), Health IT Connections program that connects health IT innovators with leading healthcare corporations, like NTT DATA. NJII’s Health IT Connections program is funded in part from JPMorgan Chase’s Small Business Forward initiative.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
